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Preclinical Evaluation of the Anti-Cancer Activity of Natural Health Extracts in Non-Hodgkins Lymphoma 
Cells 
Cancer is the leading cause of death in Canada and it is predicted that 2 out of 5 Canadians will develop the 
disease in their life time. Current cancer therapies include radiation, surgery, and chemotherapy. In most cases, 
chemotherapy is associated with severe side effects that include formation of secondary malignancies and even 
death. 
As a result, many researchers have been studying various novel anti-cancer agents, in the hopes of 
discovering new therapies that are safer and more effective. A majority of anti-cancer agents have been obtained or 
derived from natural health products, however, anecdotal evidence indicates that benefits of the whole extract 
remains unexplored. Thus, it is important for scientific research to explore whether traditionally used natural extracts 
possess anti-cancer properties. This project aims to uncover natural health products, especially lemon grass and 
hibiscus extracts, as potential anti-cancer agents against Non-Hodgkin's Lymphoma. This project aims to explore the 
mechanism(s) of action and the pharmacologically active components within lemon grass and hibiscus extracts to 
investigate the anti-cancer properties of on U-937 lymphoma cells. 
The extracts will be prepared with various solvents; hot water, cold water and ethanol. Preliminary 
screenings will be done using a WST-1 assay to determine cytotoxicity and effective doses of these extracts. This 
involves treating the cells with seven different doses of the drug, then observing the cell viability after 48 and 96 hours 
by recording the absorbance of WST-1 dye. Fluorescence microscopy and image based cytometry will be used to 
investigate the induction of programmed cell death. Apoptosis (cell suicide) will be assessed by Annexin-V staining, 
Necrosis will be assessed by propidium iodide staining, and autophagy (self eating) will be assessed by 
monodansylcadaverine. Chronology of biochemical events after treatment with these extracts will also be assessed 
through fluorescence microscopy, image based cytometry and western blotting analysis. 
Lemon grass extracted in ethanol and hibiscus extracted in cold water have shown very promising results in 
preliminary WST-1 screenings. The most effective doses are currently being examined further to determine the mode 
of cell death being induced by the extracts. The selectivity and mechanisms of cell death will then be investigated. 
These results will help to determine if lemon grass and hibiscus can be used as safe and effective treatments for 
Non-Hodgkin's lymphoma. 
 
